1	RB	RB	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	novel	novel	_	_	_	_	_	_	_
5	E2F-1	e2f-1	_	_	_	_	_	_	_
6	binding	binding	_	_	_	_	_	_	_
7	protein	protein	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	MHC	MHC	_	_	_	_	_	_	_
10	class	class	_	_	_	_	_	_	_
11	II	ii	_	_	_	_	_	_	_
12	deficient	deficient	_	_	_	_	_	_	_
13	B-cell	b-cell	_	_	_	_	_	_	_
14	lines	line	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	normal	normal	_	_	_	_	_	_	_
17	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
18	induction	induction	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	class	class	_	_	_	_	_	_	_
22	IL	IL	_	_	_	_	_	_	_
23	transactivator	transactivator	_	_	_	_	_	_	_
24	CIITA	CIITA	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	class	class	_	_	_	_	_	_	_
27	II	ii	_	_	_	_	_	_	_
28	non-inducible	non-inducible	_	_	_	_	_	_	_
29	RB-defective	rb-defective	_	_	_	_	_	_	_
30	tumor	tumor	_	_	_	_	_	_	_
31	lines	line	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	major	major	_	_	_	_	_	_	_
3	histocompatibility	histocompatibility	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	MHC	MHC	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	class	class	_	_	_	_	_	_	_
8	II	ii	_	_	_	_	_	_	_
9	genes	gene	_	_	_	_	_	_	_
10	encode	encode	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	surface	surface	_	_	_	_	_	_	_
13	proteins	protein	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	bind	bind	_	_	_	_	_	_	_
16	antigenic	antigenic	_	_	_	_	_	_	_
17	peptide	peptide	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	presentation	presentation	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	T-cells	T-cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	class	class	_	_	_	_	_	_	_
3	II	ii	_	_	_	_	_	_	_
4	proteins	protein	_	_	_	_	_	_	_
5	are	be	_	_	_	_	_	_	_
6	expressed	express	_	_	_	_	_	_	_
7	constitutively	constitutively	_	_	_	_	_	_	_
8	on	on	_	_	_	_	_	_	_
9	B-cells	B-cell	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	EBV-transformed	ebv-transformed	_	_	_	_	_	_	_
12	B-cells	B-cell	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	are	be	_	_	_	_	_	_	_
16	inducible	inducible	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
19	on	on	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	wide	wide	_	_	_	_	_	_	_
22	variety	variety	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	types	type	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Retinoblastoma	retinoblastoma	_	_	_	_	_	_	_
2	protein	protein	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	RB	RB	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	tumor	tumor	_	_	_	_	_	_	_
9	suppressor	suppressor	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	functions	function	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	transcriptional	transcriptional	_	_	_	_	_	_	_
15	repressor	repressor	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	binding	bind	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	inactivating	inactivate	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	transactivator	transactivator	_	_	_	_	_	_	_
22	E2F-I	E2F-I	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	RB-defective	rb-defective	_	_	_	_	_	_	_
2	tumor	tumor	_	_	_	_	_	_	_
3	lines	line	_	_	_	_	_	_	_
4	are	be	_	_	_	_	_	_	_
5	non-inducible	non-inducible	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	MHC	MHC	_	_	_	_	_	_	_
8	class	class	_	_	_	_	_	_	_
9	II	ii	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	or	or	_	_	_	_	_	_	_
14	very	very	_	_	_	_	_	_	_
15	weakly	weakly	_	_	_	_	_	_	_
16	inducible	inducible	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	but	but	_	_	_	_	_	_	_
19	transfection	transfection	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	2	2	_	_	_	_	_	_	_
22	different	different	_	_	_	_	_	_	_
23	lines	line	_	_	_	_	_	_	_
24	with	with	_	_	_	_	_	_	_
25	RB	RB	_	_	_	_	_	_	_
26	expression	expression	_	_	_	_	_	_	_
27	vectors	vector	_	_	_	_	_	_	_
28	re-establishes	re-establishe	_	_	_	_	_	_	_
29	or	or	_	_	_	_	_	_	_
30	substantially	substantially	_	_	_	_	_	_	_
31	enhances	enhance	_	_	_	_	_	_	_
32	class	class	_	_	_	_	_	_	_
33	II	ii	_	_	_	_	_	_	_
34	inducibility	inducibility	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Therefore	therefore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	examined	examine	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	RB	RB	_	_	_	_	_	_	_
7	status	status	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	series	series	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	B-cell	b-cell	_	_	_	_	_	_	_
13	mutants	mutant	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	are	be	_	_	_	_	_	_	_
16	defective	defective	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	class	class	_	_	_	_	_	_	_
19	II	ii	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	generated	generate	_	_	_	_	_	_	_
23	either	either	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	vitro	vitro	_	_	_	_	_	_	_
26	or	or	_	_	_	_	_	_	_
27	derived	derive	_	_	_	_	_	_	_
28	from	from	_	_	_	_	_	_	_
29	Bare	Bare	_	_	_	_	_	_	_
30	Lymphocyte	Lymphocyte	_	_	_	_	_	_	_
31	Syndrome	Syndrome	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	BLS	BLS	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	patients	patient	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	matrix-bound	matrix-bound	_	_	_	_	_	_	_
3	RB	rb	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	detectable	detectable	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	all	all	_	_	_	_	_	_	_
8	cases	case	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	indicating	indicate	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	loss	loss	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	RB	RB	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	responsible	responsible	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	decreased	decrease	_	_	_	_	_	_	_
20	class	class	_	_	_	_	_	_	_
21	II	ii	_	_	_	_	_	_	_
22	expression	expression	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	these	these	_	_	_	_	_	_	_
25	lines	line	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	second	second	_	_	_	_	_	_	_
3	E2F-I	E2F-I	_	_	_	_	_	_	_
4	binding	binding	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	most	most	_	_	_	_	_	_	_
8	likely	likely	_	_	_	_	_	_	_
9	DP-I	DP-I	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	also	also	_	_	_	_	_	_	_
13	apparently	apparently	_	_	_	_	_	_	_
14	normal	normal	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	both	both	_	_	_	_	_	_	_
17	class	class	_	_	_	_	_	_	_
18	II-positive	ii-positive	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	-negative	-negative	_	_	_	_	_	_	_
21	B-cell	b-cell	_	_	_	_	_	_	_
22	lines	line	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
6	induction	induction	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	CIITA	CIITA	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	RB-defective	rb-defective	_	_	_	_	_	_	_
11	lines	line	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	CIITA	CIITA	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	class	class	_	_	_	_	_	_	_
5	II	ii	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	transactivator	transactivator	_	_	_	_	_	_	_
8	known	know	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	be	be	_	_	_	_	_	_	_
11	defective	defective	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	one	one	_	_	_	_	_	_	_
14	form	form	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	BLS	bls	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	be	be	_	_	_	_	_	_	_
20	required	require	_	_	_	_	_	_	_
21	for	for	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	induction	induction	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	MHC	MHC	_	_	_	_	_	_	_
26	class	class	_	_	_	_	_	_	_
27	II	ii	_	_	_	_	_	_	_
28	by	by	_	_	_	_	_	_	_
29	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	CIITA	CIITA	_	_	_	_	_	_	_
2	mRNA	mRNA	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	normally	normally	_	_	_	_	_	_	_
5	inducible	inducible	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	class	class	_	_	_	_	_	_	_
10	II	ii	_	_	_	_	_	_	_
11	non-inducible	non-inducible	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	RB-defective	rb-defective	_	_	_	_	_	_	_
14	lines	line	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	one	one	_	_	_	_	_	_	_
19	line	line	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	re-expression	re-expression	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	RB	RB	_	_	_	_	_	_	_
24	has	have	_	_	_	_	_	_	_
25	no	no	_	_	_	_	_	_	_
26	effect	effect	_	_	_	_	_	_	_
27	on	on	_	_	_	_	_	_	_
28	CIITA	CIITA	_	_	_	_	_	_	_
29	mRNA	mRNA	_	_	_	_	_	_	_
30	induction	induction	_	_	_	_	_	_	_
31	levels	level	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	block	block	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	MHC	MHC	_	_	_	_	_	_	_
7	class	class	_	_	_	_	_	_	_
8	II	ii	_	_	_	_	_	_	_
9	inducibility	inducibility	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	RB-defective	rb-defective	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	due	due	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	block	block	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	CIITA	CIITA	_	_	_	_	_	_	_
21	inducibility	inducibility	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

